Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV

NCT00244712 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

688

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: emtricitabine/tenofovir
DRUG: abacavir/lamivudine

Sponsor

GlaxoSmithKline